Skip to Main Content

Paper Details

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Am J Hum Genet
2
2023
GW, PRS, men, prostate, prostate cancer, prostate cancer-risk variants
Author NameAffiliation
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Fred Hutchinson Cancer Center
Burcu F DarstCenter for Genetic Epidemiology, Keck School of Medicine, University of Southern California, Fred Hutchinson Cancer Center
Tokhir DadaevThe Institute of Cancer Research
Loic Le MarchandUniversity of Hawaii Cancer Center
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Johanna SchleutkerInstitute of Biomedicine, University of Turku
Cezary CybulskiInternational Hereditary Cancer Center, Pomeranian Medical University
David E NealUniversity of Oxford, John Radcliffe Hospital, UK University of Cambridge, Addenbrooke's Hospital, Cambridge Research Institute
Børge G NordestgaardUniversity of Copenhagen, Herlev and Gentofte Hospital, Copenhagen University Hospital
Sune F NielsenUniversity of Copenhagen, Herlev and Gentofte Hospital, Copenhagen University Hospital
Judith A ClementsAustralian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Australia Translational Research Institute
Henrik Gr??nbergKarolinska Institute
Henrik Gr??nbergKarolinska Institute
Ruth C TravisUniversity of Oxford
Demetrius AlbanesNational Cancer Institute
Stephanie J WeinsteinNational Cancer Institute
Lorelei A MucciHarvard T. H. Chan School of Public Health
David J HunterUniversity of Oxford
David J HunterUniversity of Oxford
Kathryn L PenneyBrigham and Women's Hospital/Harvard Medical School
Janet L StanfordFred Hutchinson Cancer Center, School of Public Health, University of Washington
Janet L StanfordFred Hutchinson Cancer Center, School of Public Health, University of Washington
William J BlotVanderbilt University Medical Center, USA International Epidemiology Institute
Yong-Jie LuBarts Cancer Institute, Queen Mary University of London
Daniel J SchaidMayo Clinic
Stephen N ThibodeauMayo Clinic
Catharine M L WestUniversity of Manchester, The Christie Hospital NHS Foundation Trust
Esther M JohnStanford University School of Medicine, USA Stanford Cancer Institute
Kay-Tee KhawClinical Gerontology Unit, University of Cambridge
Sue A InglesKeck School of Medicine, University of Southern California
Barry S RosensteinIcahn School of Medicine at Mount Sinai
Chad D HuffThe University of Texas M. D. Anderson Cancer Center
Robin J LeachCancer Therapy and Research Center, University of Texas Health Science Center at San Antonio
Rick A Kittles
William B IsaacsJames Buchanan Brady Urological Institute, Johns Hopkins Hospital and Medical Institution
John D CarptenKeck School of Medicine, University of Southern California
Jianfeng XuNorthShore University HealthSystem
Dana C CrawfordCase Western Reserve University, Cleveland Institute for Computational Biology
Dana C CrawfordCase Western Reserve University, Cleveland Institute for Computational Biology
Gyorgy PetrovicsCenter for Prostate Disease Research, Uniformed Services University
Gyorgy PetrovicsCenter for Prostate Disease Research, Uniformed Services University
Monique J RoobolErasmus University Medical Center, Cancer Institute
Sonja I BerndtNational Cancer Institute
Stephen K Van Den EedenKaiser Permanente, University of California San Francisco
Douglas F EastonUniversity of Cambridge
Stephen J ChanockNational Cancer Institute
Stephen J ChanockNational Cancer Institute
Fredrik WiklundKarolinska Institute
John S WitteStanford Cancer Institute
Rosalind A EelesThe Institute of Cancer Research, UK Royal Marsden NHS Foundation Trust
  • 1 - 50

Datasets